Evoke (+) trials of semaglutide for early alzheimer’s disease: Innovations, lessons, and implications

The Journal of Prevention of Alzheimer's Disease · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles